PL2801373T3 - Lek do podawania miejscowego w leczeniu zaburzeń połykania - Google Patents
Lek do podawania miejscowego w leczeniu zaburzeń połykaniaInfo
- Publication number
- PL2801373T3 PL2801373T3 PL12859657T PL12859657T PL2801373T3 PL 2801373 T3 PL2801373 T3 PL 2801373T3 PL 12859657 T PL12859657 T PL 12859657T PL 12859657 T PL12859657 T PL 12859657T PL 2801373 T3 PL2801373 T3 PL 2801373T3
- Authority
- PL
- Poland
- Prior art keywords
- local administration
- type pharmaceutical
- improving dysphagia
- dysphagia
- improving
- Prior art date
Links
- 208000019505 Deglutition disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Psychology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011280365 | 2011-12-21 | ||
| EP12859657.4A EP2801373B1 (en) | 2011-12-21 | 2012-12-20 | Local administration-type pharmaceutical for improving dysphagia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2801373T3 true PL2801373T3 (pl) | 2017-07-31 |
Family
ID=48668562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12859657T PL2801373T3 (pl) | 2011-12-21 | 2012-12-20 | Lek do podawania miejscowego w leczeniu zaburzeń połykania |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9675547B2 (pl) |
| EP (1) | EP2801373B1 (pl) |
| JP (1) | JP5828007B2 (pl) |
| KR (1) | KR101896441B1 (pl) |
| CN (3) | CN104125837A (pl) |
| ES (1) | ES2616960T3 (pl) |
| PL (1) | PL2801373T3 (pl) |
| WO (1) | WO2013094682A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2801373T3 (pl) * | 2011-12-21 | 2017-07-31 | Meiji Seika Pharma Co., Ltd. | Lek do podawania miejscowego w leczeniu zaburzeń połykania |
| JPWO2014199486A1 (ja) * | 2013-06-13 | 2017-02-23 | Meiji Seikaファルマ株式会社 | 嚥下障害改善用医薬品 |
| US9974768B2 (en) | 2013-06-13 | 2018-05-22 | Meiji Seika Pharma Co., Ltd. | Pharmaceutical for improving dysphagia |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2824477B1 (fr) | 2001-05-09 | 2005-09-09 | Ethypharm Lab Prod Ethiques | Granules enrobes a base d'inhibiteur de l'enzyme de conversion de l'anfiotensine, leur procede de preparation et comprimes orodispersibles contenant les granules enrobes |
| JP2004107285A (ja) | 2002-09-20 | 2004-04-08 | Mercian Corp | 嚥下障害改善剤 |
| JP2006511617A (ja) | 2002-12-13 | 2006-04-06 | アダーギット | 製薬用多孔質粒子 |
| CN100431553C (zh) * | 2002-12-26 | 2008-11-12 | 株式会社山田养蜂场本社 | 改善咽下障碍用组合物 |
| US8992974B2 (en) * | 2003-02-24 | 2015-03-31 | Pharmaceuticals Productions, Inc. | Transmucosal drug delivery system |
| JP2004300403A (ja) | 2003-03-18 | 2004-10-28 | Jsr Corp | (メタ)アクリル系重合体および感放射線性樹脂組成物 |
| JP3762969B2 (ja) | 2003-03-31 | 2006-04-05 | 株式会社東北テクノアーチ | 嚥下障害改善剤 |
| WO2005099670A1 (en) * | 2004-03-31 | 2005-10-27 | Richard Soltero | Method for administering medicaments to subjects with swallowing difficulties and disorders |
| EP2767163A1 (en) | 2005-02-17 | 2014-08-20 | Abbott Laboratories | Transmucosal administration of drug compositions for treating and preventing disorders in animals |
| JP5366558B2 (ja) | 2006-12-28 | 2013-12-11 | 武田薬品工業株式会社 | 口腔内崩壊性固形製剤 |
| US20100221340A1 (en) * | 2007-09-20 | 2010-09-02 | University Of Rochester | Method and compositions for treatment or prevention of inflammatory conditions |
| GB0801876D0 (en) | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
| GB0900622D0 (en) * | 2009-01-15 | 2009-02-25 | Williams Paul | A method for diagnosing urticaria and angioedema |
| EP2429495A4 (en) | 2009-05-15 | 2014-01-22 | Shin Nippon Biomedical Lab Ltd | INTRANASAL PHARMACEUTICAL COMPOSITION WITH IMPROVED PHARMACOKINETICS |
| PL2801373T3 (pl) * | 2011-12-21 | 2017-07-31 | Meiji Seika Pharma Co., Ltd. | Lek do podawania miejscowego w leczeniu zaburzeń połykania |
| US9974768B2 (en) * | 2013-06-13 | 2018-05-22 | Meiji Seika Pharma Co., Ltd. | Pharmaceutical for improving dysphagia |
-
2012
- 2012-12-20 PL PL12859657T patent/PL2801373T3/pl unknown
- 2012-12-20 JP JP2013550328A patent/JP5828007B2/ja not_active Expired - Fee Related
- 2012-12-20 ES ES12859657.4T patent/ES2616960T3/es active Active
- 2012-12-20 US US14/367,755 patent/US9675547B2/en not_active Expired - Fee Related
- 2012-12-20 CN CN201280070003.1A patent/CN104125837A/zh active Pending
- 2012-12-20 KR KR1020147019672A patent/KR101896441B1/ko not_active Expired - Fee Related
- 2012-12-20 WO PCT/JP2012/083062 patent/WO2013094682A1/ja not_active Ceased
- 2012-12-20 CN CN201810427404.7A patent/CN108853093A/zh active Pending
- 2012-12-20 CN CN201710025941.4A patent/CN107049997A/zh active Pending
- 2012-12-20 EP EP12859657.4A patent/EP2801373B1/en active Active
-
2017
- 2017-05-08 US US15/588,930 patent/US10052281B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20170266111A1 (en) | 2017-09-21 |
| JPWO2013094682A1 (ja) | 2015-04-27 |
| HK1200108A1 (en) | 2015-07-31 |
| EP2801373A4 (en) | 2015-10-07 |
| CN108853093A (zh) | 2018-11-23 |
| US20150297512A1 (en) | 2015-10-22 |
| US9675547B2 (en) | 2017-06-13 |
| WO2013094682A1 (ja) | 2013-06-27 |
| ES2616960T3 (es) | 2017-06-14 |
| KR20140116105A (ko) | 2014-10-01 |
| US10052281B2 (en) | 2018-08-21 |
| KR101896441B1 (ko) | 2018-09-11 |
| CN107049997A (zh) | 2017-08-18 |
| EP2801373A1 (en) | 2014-11-12 |
| JP5828007B2 (ja) | 2015-12-02 |
| CN104125837A (zh) | 2014-10-29 |
| EP2801373B1 (en) | 2017-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3864A (en) | Pharmaceutical composition | |
| DK3505720T3 (en) | Cementering under styret tryk | |
| SG10201601802YA (en) | Dispiropyrrolidine derivatives | |
| GB201109414D0 (en) | Diathermy -ionisation technique | |
| IL231229A0 (en) | New history of dihydroquinoline-2-one | |
| LT2729179T (lt) | Makromolekulės | |
| ZA201307273B (en) | Merchandiser | |
| GB201118232D0 (en) | Pharmaceutical composition | |
| SG11201401937YA (en) | New aryl-quinoline derivatives | |
| IL247640A0 (en) | History of heteroaryl piperidine | |
| ZA201308157B (en) | Pharmaceutical composition | |
| EP2727593A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL | |
| SI2766342T1 (sl) | Derivati fenil-gvanidina | |
| EP2716258A4 (en) | INTRASTOMAL SEGMENT | |
| EP2711010A4 (en) | PHARMACEUTICAL COMPOSITION | |
| PL2801373T3 (pl) | Lek do podawania miejscowego w leczeniu zaburzeń połykania | |
| ZA201308049B (en) | 3-ureidoisoquinolin-8-yl derivatives | |
| PL2665867T3 (pl) | Tor | |
| HUP1100444A2 (en) | Pharmaceutical composition | |
| ZA201305677B (en) | Passage barrier | |
| HUP1100445A2 (en) | Pharmaceutical composition | |
| GB201119796D0 (en) | Pharmaceutical comopounds | |
| IL215425A0 (en) | Anti-vchicle barrier | |
| GB201105337D0 (en) | Barrier | |
| PL119701U1 (pl) | Bariera |